Best Medical Device Market Research Companies
Compare leading medical device market research companies for 2026. Find verified HCP panels and expert insights to inform your global strategy and launch.
Quick answer
For large-scale clinical evidence and commercial strategy, IQVIA; for specialized patient and HCP engagement, Ipsos; for agile, high-quality panel access across 190 markets, Global Vox Populi; for DIY quantitative research, Sago.
Medical device manufacturers operating in worldwide markets face a complex environment where product adoption depends on evidence-based insights from diverse stakeholders. Selecting the right medical device market research companies requires balancing the need for rigorous, clinical-grade data against the speed required to work through shifting regulatory and market conditions.
This assessment examines leading research providers, evaluating their capacity to deliver high-fidelity data from niche audiences such as surgeons, hospital administrators, and specialized patients. Decision-makers must weigh a partner’s ability to handle global regulatory compliance against the practical necessity of accessing reliable, verified respondent panels to inform product development, launch strategies, and post-market surveillance. The following analysis provides a structured comparison to help procurement leads and brand managers select a partner that aligns with their specific therapeutic and commercial requirements in 2026.
Best Medical Device Market Research Companies: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Ipsos | Healthcare professional insights | 88.5 |
| 2 | IQVIA | Real-world evidence and clinical data | 86.5 |
| 3 | Global Vox Populi | Global primary research with proprietary panels | 84.0 |
| 4 | Kantar | Brand equity and consumer understanding | 82.5 |
| 5 | Sago | Agile testing and facility-based research | 79.0 |
| 6 | Dynata | Large-scale first-party data collection | 78.5 |
| 7 | Escalent | AI-enabled strategic advisory | 73.5 |
| 8 | Savanta | B2B and professional services research | 73.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Ipsos | Doctors, patients, healthcare professionals | Proprietary panel authentication | Not stated on pages reviewed | Project quote | Not published | Not published |
| IQVIA | Healthcare providers, patients, payers | Proprietary database and medical records | Not stated on pages reviewed | Project quote | Not published | Not published |
| Global Vox Populi | HCPs, patients, caregivers, IT decision-makers | License checks, company records, identity fingerprinting | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 29,093,467 B2C consumers; 4,912,644 B2B professionals; 2,738,904 healthcare professionals (worldwide; Global Vox Populi panel records, Oct 2026) | Not published |
| Kantar | Consumers, caregivers, patients | Qubed AI fraud detection and panel management | Not stated on pages reviewed | Project quote | Not published | Not published |
| Sago | Healthcare professionals, consumers | SagoVerify data quality pledge | Not stated on pages reviewed | Project quote / Subscription | 176 million respondents surveyed (sago.com, Oct 2026) | Not published |
| Dynata | Consumers, professionals, voters | QualityScore ML model and multi-layered verification | Not stated on pages reviewed | Per complete / Project quote | 70M+ global panelists (dynata.com, Oct 2026) | Not published |
| Escalent | Healthcare professionals, consumers, business leaders | Internal quality protocols | Not stated on pages reviewed | Project quote | Not published | Not published |
| Savanta | Business decision-makers, stakeholders | Internal research quality standards | Not stated on pages reviewed | Project quote | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Ipsos | ● | ● | – | ● | – | ● |
| IQVIA | ● | – | – | ● | – | – |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Kantar | ● | ● | ● | ● | – | ● |
| Sago | ● | ● | – | ● | – | ● |
| Dynata | ● | ● | ● | ● | ● | ● |
| Escalent | ● | ● | – | ● | – | – |
| Savanta | ● | – | – | ● | ● | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Standardized evaluation protects consistent assessment of research rigor and operational reliability across all providers.
| Criterion | Weight | What it means here |
|---|---|---|
| Research Quality | 20 | This criterion measures the integrity of survey design, analytical methods, and the validity of insights delivered. Good performance requires adherence to rigorous scientific standards, transparent documentation of methodology, and the ability to produce reliable findings that stand up to the scrutiny of internal clinical or regulatory stakeholders. |
| Methodological Breadth | 15 | The capacity to deploy diverse research techniques, including qualitative focus groups, in-depth interviews, online surveys, and advanced analytics like conjoint or MaxDiff. A high-performing firm offers a balanced mix of methodologies to address different stages of the product lifecycle, from concept testing to post-launch performance monitoring. |
| Fieldwork Capability | 15 | The operational strength to execute projects across multiple countries and modes. This involves effective recruitment, skilled moderation for qualitative sessions, and competent survey programming. Good fieldwork makes sure that data collection remains on schedule and that the respondents gathered actually match the specific professional or patient profiles required. |
| Sample Quality and Verification | 10 | This measures the sourcing and authentication of respondents. Top-tier providers use proprietary panels with multi-layered verification, including license checks for professionals and identity fingerprinting. This makes sure that the data represents authentic experts or patients rather than low-quality individuals sourced from open exchanges or unreliable third-party lists. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Compliance, Certifications and Security | 10 | The firm’s adherence to international standards like ISO 20252 and ISO/IEC 27001, alongside compliance with GDPR, HIPAA, and industry-specific codes. Good firms provide clear evidence of data protection, secure handling of sensitive health information, and established protocols for reporting adverse events during research sessions with patients or doctors. |
| Analytical Capability | 10 | The ability to synthesize raw data into strategic, actionable business intelligence. A strong firm goes beyond simple reporting to provide insights that directly address the client's business questions, offering clear recommendations for brand positioning, market entry, or product refinement based on complex healthcare market dynamics. |
| Client Service and Speed | 5 | Responsiveness, clarity in project management, and the ability to meet tight deadlines without compromising data integrity. High-quality service involves proactive communication about potential delays and professional handling of challenges, making sure that the research process is as efficient as possible for the client’s internal teams. |
| Pricing and Feasibility Transparency | 5 | Honest and clear communication regarding project feasibility, incidence rates, and costs before work begins. Good partners provide accurate estimates of what is achievable given the budget and timeline, helping clients avoid unrealistic project designs or unexpected costs during the research process. |
Why these weights. For full-service work, the quality of the research design decides whether the answer can be trusted, so it leads (20). Methods and fieldwork (15 each) decide whether that design can be executed in this market. Sample quality, compliance and analysis (10 each) separate good partners from adequate ones; service and pricing transparency (5 each) are tie-breakers. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: medical device market research companies worldwide
Ipsos: best for healthcare professional insights

Strongest fitFirms requiring deep healthcare professional insights and strategic guidance in regulated markets.
Ipsos maintains a strong focus on the healthcare sector through its specialized centres of expertise. Its approach integrates surveys, social media data, and qualitative research to provide a comprehensive view of patient and professional opinions.
The company is particularly well-regarded for its tracking of healthcare system perceptions and its ability to engage diverse audiences, including doctors and patients. For medical device companies, Ipsos offers the methodological rigor needed to support product development and market access strategies.
Scorecard: 88.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Research Quality | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Methodological Breadth | 15 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Fieldwork Capability | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Sample Quality and Verification | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Compliance, Certifications and Security | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 88.5 |
Core services
- Healthcare Consulting: Strategic advice for the medical device and diagnostics sector.
- Market Strategy: Understanding market dynamics and competitor positioning.
- Qualitative Research: Deep-dive sessions to understand patient and HCP behaviors.
Strengths
- Healthcare Expertise: Dedicated Medical Devices & Diagnostics Centre of Expertise.
- Global Trends: Provides long-term tracking of global healthcare system performance.
Innovation and technology
- Augmented Ipsos: New corporate initiatives integrating AI into research delivery.
Impact on businesses
- Informed Decision-Making: Translates complex healthcare data into actionable strategic recommendations.
Why it may fit your brief
It is a top choice for healthcare-specific research. A firm seeking a broad, general-purpose research partner for non-health segments might consider other options.
IQVIA: best for real-world evidence and clinical data

Strongest fitGlobal medical device firms needing large-scale evidence for regulatory filings or commercial positioning.
IQVIA combines massive proprietary datasets with advanced analytics to support the entire medical device product lifecycle. Its presence in over 100 countries allows for deep, evidence-based research that connects clinical development with commercial execution.
The firm focuses on asset maximization, using patient records and predictive modeling to help clients work through competitive environments. For medical device firms, IQVIA offers the scale and therapeutic expertise necessary to understand complex market dynamics, particularly in heavily regulated sectors.
Scorecard: 86.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Research Quality | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Methodological Breadth | 15 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Fieldwork Capability | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Sample Quality and Verification | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Compliance, Certifications and Security | 10 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 86.5 |
Core services
- Clinical Development: Full-service clinical trial management and site identification.
- Commercial Intelligence: Market-specific insights and sales performance benchmarking.
- Real-World Evidence: Using proprietary patient records to track outcomes and adherence.
Strengths
- Data Infrastructure: Access to petabytes of proprietary, non-identified patient records.
- Therapeutic Expertise: Specialized teams focused on specific medical areas and clinical trial operations.
Innovation and technology
- IQVIA.ai Platform: A unified agentic platform designed to accelerate decision-making through AI.
Impact on businesses
- Asset Maximization: Helps clients optimize development timelines and commercial success probability.
Why it may fit your brief
It is ideal for large-scale clinical and commercial intelligence projects. Firms looking for smaller, agile qualitative research projects might find more suitable partners elsewhere.
Global Vox Populi: best for global primary research with proprietary panels
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitA research director or brand manager needing reliable access to specialized healthcare professionals for global market assessment.
Global Vox Populi operates as a primary research firm with a focus on verified, high-quality data collection for international clients. Its infrastructure is built around proprietary proprietary panel assets, protecting consistent access to specialized audiences without reliance on third-party sample exchanges.
The firm provides full-service solutions, covering everything from qualitative in-depth interviews to large-scale quantitative tracking. By maintaining direct ownership of its panels, it achieves high standards in respondent profiling and verification, making it a reliable choice for complex projects requiring high-precision targeting in worldwide markets.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
B2C consumer panel, worldwide, 170 markets
29,093,467 panellists
B2B and IT decision-maker panel, worldwide, 170 markets
4,912,644 panellists
Healthcare professionals panel, worldwide, 170 markets
2,738,904 panellists
Key opinion leader panel, worldwide, 170 markets
192,167 panellists
Scorecard: 84.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Research Quality | 20 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Methodological Breadth | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Fieldwork Capability | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Sample Quality and Verification | 10 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Compliance, Certifications and Security | 10 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Analytical Capability | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 84.0 |
Core services
- Primary Data Collection: Full-service fieldwork execution across qualitative and quantitative modes using an internal platform.
- Panel Management: Direct ownership and verification of proprietary B2C and B2B panels.
- Expert Interviewing: Supporting one-on-one sessions with healthcare professionals and KOLs for deep market insights.
Strengths
- Proprietary Panel Depth: Maintains 46,023,988 panellists across 199 markets, including 2,738,904 healthcare professionals and 3,230,728 nurses and allied health members.
- Verified Recruitment: Identity verification for professionals against license or company records, coupled with regular re-profiling of all members.
- Data Quality Controls: Advanced detection for speeding, straight-lining, and fraudulent activity, including device fingerprinting and geo-location checks.
Innovation and technology
- Integrated Technology: Surveys are hosted on a proprietary platform, allowing for smooth integration of mobile and WhatsApp-assisted data collection.
- AI-Driven Quality: Real-time monitoring of response quality and bot detection to protect high data integrity throughout the fieldwork process.
Impact on businesses
- Strategic Decision Support: Delivers actionable intelligence for product launch and market positioning based on verified stakeholder feedback.
- Risk Mitigation: Protects compliance with international data protection laws, providing a secure environment for sensitive healthcare insights.
Why it may fit your brief
It fits well when the priority is high-quality sample from verified sources rather than open-market recruitment. If a client requires extensive clinical trial management or CRO-style services, they might look elsewhere.
Kantar: best for brand equity and consumer understanding

Strongest fitBrands seeking to understand consumer perceptions and test creative concepts effectively.
Kantar uses deep consumer intelligence to help brands optimize their market presence. With operations in 100 markets, it provides tools that integrate survey data with behavioral science frameworks to support strategic business growth.
The company emphasizes high-quality data through its anti-fraud technology and proprietary premium panels. For medical device companies, Kantar offers the ability to map the patient and caregiver experience against broader consumer trends, making sure that marketing and product positioning remain grounded in human reality.
Scorecard: 82.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Research Quality | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Methodological Breadth | 15 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Fieldwork Capability | 15 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Sample Quality and Verification | 10 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Compliance, Certifications and Security | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 10 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 82.5 |
Core services
- Brand Strategy: Consulting on brand equity and market positioning.
- Survey Solutions: Custom and DIY research tools for global markets.
- Data Integration: Connecting survey results with third-party data sources.
Strengths
- Panel Quality: Owns and operates six proprietary Premium Panels with advanced fraud detection.
- Global Reach: Consistent fieldwork delivery across 100 markets.
Innovation and technology
- Qubed AI: Proprietary technology designed to stop panel fraud using deep neural networks.
Impact on businesses
- Brand Growth: Provides clear roadmaps for improving brand salience and market share.
Why it may fit your brief
It fits brands focused on consumer-facing communication and brand health. Specialized clinical research might be better suited to firms with deeper healthcare-only focus.
Sago: best for agile testing and facility-based research

Strongest fitTeams that need a mix of facility-based qualitative work and agile quantitative testing.
Sago provides a versatile platform for researchers needing to combine in-person facilities with digital connectivity. Its history in qualitative recruitment makes it a strong partner for concept testing and stakeholder engagement.
The firm offers a range of tools to manage the end-to-end research process, including DIY options. For medical device companies, Sago provides the flexibility to conduct both traditional facility-based focus groups and modern digital surveys under one roof.
Scorecard: 79.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Research Quality | 20 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Methodological Breadth | 15 | 9/10 | sago.com (4 pages reviewed), Oct 2026 |
| Fieldwork Capability | 15 | 9/10 | sago.com (4 pages reviewed), Oct 2026 |
| Sample Quality and Verification | 10 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Compliance, Certifications and Security | 10 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 10 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.0 |
Core services
- Testing Facilities: High-tech viewing spaces for in-person qualitative research.
- Participant Recruitment: Global reach to specialized healthcare and consumer audiences.
- DIY Quant: Self-serve platform for rapid quantitative research.
Strengths
- Hybrid Capability: Combines physical facilities with digital qualitative tools.
- Agile Testing: Supports rapid concept and creative testing for fast market feedback.
Innovation and technology
- Methodify: Self-serve platform for faster, easier quantitative research.
Impact on businesses
- Faster Insights: Shrinks timelines for creative and product testing through agile workflows.
Why it may fit your brief
It is perfect for agile research requirements. Firms needing only massive secondary data analytics might prefer a data-heavy provider.
Dynata: best for large-scale first-party data collection

Strongest fitCompanies needing high-speed, large-scale quantitative data from niche audiences.
Dynata operates one of the largest first-party data platforms globally, offering researchers the ability to reach highly specific audiences. Its focus on quality assurance through AI-powered models makes it a reliable partner for quantitative projects.
The company supports a wide range of methodologies, including phone, SMS, and online surveys. For medical device researchers, Dynata provides the scale needed to reach hard-to-find professional groups and patient populations quickly.
Scorecard: 78.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Research Quality | 20 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Methodological Breadth | 15 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Fieldwork Capability | 15 | 9/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Sample Quality and Verification | 10 | 9/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 5/10 | Google results for this search and company size, Oct 2026 |
| Compliance, Certifications and Security | 10 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 10 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.5 |
Core services
- Data Platform: Self-serve and managed access to first-party respondent panels.
- Survey Programming: Mobile-first survey design and deployment tools.
- Audience Targeting: Precision segmentation for B2B and healthcare professionals.
Strengths
- Data Scale: Access to over 70 million global panelists.
- Quality Control: Uses the QualityScore ML model to identify and remove fraudulent survey responses.
Innovation and technology
- Dynata+: A platform for research-grade data delivery with self-serve capabilities.
Impact on businesses
- Efficient Insights: Reduces data cleaning time significantly through automated quality checks.
Why it may fit your brief
It is excellent for quantitative volume. Clients needing deep, high-touch qualitative consultation might prefer a more boutique agency.
Escalent: best for AI-enabled strategic advisory

Strongest fitBrands looking for a consultative partner to guide them through complex market changes.
Escalent combines deep industry expertise with advanced analytics to help clients work through market disruption. Following its recent acquisitions, it has expanded its capacity to turn complex data into strategic guidance.
The firm places a strong emphasis on behavioral science and human-guided AI. For medical device companies, Escalent offers a consultative approach to understanding stakeholder needs and building market-responsive strategies.
Scorecard: 73.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Research Quality | 20 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Methodological Breadth | 15 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Fieldwork Capability | 15 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Sample Quality and Verification | 10 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Compliance, Certifications and Security | 10 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Analytical Capability | 10 | 9/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 73.5 |
Core services
- Strategic Advisory: Consulting on brand management and digital transformation.
- Behavioral Science: Applying psychological principles to understand customer engagement.
- Data Science: Advanced analytics to uncover behavioral patterns.
Strengths
- Industry Bench: Dedicated specialists in healthcare and life sciences.
- AI Governance: Responsible, human-in-the-loop AI integration in research workflows.
Innovation and technology
- Human-Guided AI: Using AI to enhance industry knowledge rather than replacing it.
Impact on businesses
- Actionable Intelligence: Transforms complex data into strategic insights for brand development.
Why it may fit your brief
It is strong for strategy and behavioral insights. A firm needing only basic data collection might find it more specialized than required.
Savanta: best for B2B and professional services research

Strongest fitCompanies needing B2B insights and strategic recommendations to improve brand positioning.
Savanta provides a blend of data collection and high-impact consulting to help clients make informed business decisions. Its focus on the B2B sector is particularly notable, with experience in engaging time-scarce decision-makers.
The company offers a modular suite of research products designed to provide value at different stages of the research cycle. For medical device companies, Savanta provides the grounded recommendations needed to work through brand positioning and product development in complex B2B environments.
Scorecard: 73.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Research Quality | 20 | 8/10 | savanta.com (4 pages reviewed), Oct 2026 |
| Methodological Breadth | 15 | 8/10 | savanta.com (4 pages reviewed), Oct 2026 |
| Fieldwork Capability | 15 | 8/10 | savanta.com (4 pages reviewed), Oct 2026 |
| Sample Quality and Verification | 10 | 7/10 | savanta.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Compliance, Certifications and Security | 10 | 7/10 | savanta.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 10 | 8/10 | savanta.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | savanta.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | savanta.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 73.5 |
Core services
- Consulting Services: Advisory on brand development and market entry.
- Market Intelligence: Instant access to market, brand, and customer data.
- Fieldwork Services: Full-range data collection and analysis.
Strengths
- B2B Expertise: Proven experience in engaging guarded and time-scarce business decision-makers.
- Modular Products: Savanta Essentials offers a low-cost, high-value alternative to traditional research.
Innovation and technology
- BrandVue: Tool providing market research insights on brand performance.
Impact on businesses
- Actionable Recommendations: Delivers findings with grounded advice that resonates with leadership teams.
Why it may fit your brief
It is excellent for B2B research. If the project requires large-scale patient clinical data, a more specialized healthcare firm might be better.
How respondent verification actually works
Respondent integrity is maintained through multi-layered verification and active panel management.
Professional Credential Verification
For medical device studies, verifying that respondents are indeed qualified healthcare professionals is critical. This involves checking professional licenses against government or industry databases to make sure the participant's background matches the study requirements. Buyers should ask providers for documented proof of how they conduct these checks. A common pitfall is relying on self-reported data, which can lead to unqualified individuals participating in specialized research, thereby compromising the validity of the findings.
Identity and Fraud Detection
Top-tier firms use sophisticated identity fingerprinting and geo-location checks to prevent bot activity and duplicate responses. These systems monitor for suspicious VPN usage and verify that the respondent is located in the target market. Buyers should request reports on how the provider handles fraud detection and what percentage of completes are typically excluded. Providers that lack these automated controls are prone to data corruption from professional survey takers or fraudulent automated scripts.
Behavioral Consistency Checks
Using trap questions and straight-lining detection helps identify respondents who are not paying attention. These checks are applied during the survey to filter out unreliable data in real-time. It is essential to make sure that the provider uses these methods to maintain data quality. When a provider fails to implement these measures, the result is often a high volume of low-quality, unusable data that can lead to incorrect business conclusions.
Panel Profiling and Maintenance
Proprietary panels are consistently maintained through regular re-profiling of members. This makes sure that the professional and patient data remains current. Buyers should inquire about the frequency of panel updates and how the provider manages member attrition. A lack of regular maintenance can lead to outdated respondent profiles, which significantly reduces the relevance and accuracy of the insights collected for specific medical device segments.
How to choose the right provider worldwide
Selecting a research partner requires matching the provider’s specific strengths to your project's unique requirements.
- Define Research Scope: Clearly distinguish between exploratory qualitative research and large-scale quantitative validation. Choose a firm that specializes in the primary methodology your project requires.
- Verify Audience Access: Confirm that the provider has direct, proprietary access to the specific healthcare professionals or patient populations needed. Avoid firms that rely heavily on third-party sample exchanges.
- Assess Regulatory Capability: Make sure the provider understands the compliance requirements for your market, including data protection laws and adverse event reporting procedures. This is essential for healthcare research.
- Evaluate Data Quality: Request detailed information on the firm’s verification and fraud detection processes. A serious partner will be transparent about how they protect the integrity of their data.
- Review Case Experience: Ask for examples of similar studies they have conducted. Experience in your specific therapeutic area or device category is often a strong indicator of future success.
Questions to ask before you commission
- What specific verification processes do you use to protect respondent credentials for healthcare professionals?
- How do you manage data quality and fraud detection during the survey fielding process?
- Can you provide examples of how your research has influenced commercial strategy for medical device clients?
- What is your protocol for reporting adverse events if they arise during a research session?
- Do you own your panels, or do you rely on third-party exchanges to fulfill sample requirements?
- How do you handle feasibility and incidence rate changes once a project is in the field?
Common pitfalls to avoid
- Ignoring Panel Ownership: Relying on open-market sample providers often leads to inconsistent data quality and poor respondent verification, which is particularly risky in healthcare research.
- Underestimating Complexity: Assuming that a generalist agency can handle specialized medical device research without deep therapeutic expertise often results in superficial insights.
- Neglecting Compliance: Failing to protect the provider follows local data protection and healthcare-specific regulations can expose your firm to significant legal and reputational risk.
- Over-focusing on Price: Prioritizing the lowest bid over methodological rigor almost always leads to unreliable data that fails to support critical business decision-making.
What a feasibility check should include
Accurate feasibility checks are the foundation of a successful research project in worldwide markets.
Incidence Rate Estimation
A proper check must realistically estimate the incidence rate of the target audience. In healthcare, this is important because specialized professionals are often difficult to reach, and inaccurate estimates can lead to project delays.
Target Audience Availability
The check should confirm the actual number of reachable respondents within the specific demographic or professional criteria. This prevents signing off on a project that cannot be completed within the desired timeframe.
Regional Regulatory Nuance
For worldwide projects, the check must account for local data protection laws and recruitment restrictions. This makes sure that the chosen methodologies are actually legal and viable in each target country.
Timeline and Budget Alignment
The feasibility process should explicitly link the number of completions to the available budget and timeline. This transparency helps manage internal expectations and avoids mid-project budget overruns.
Conclusion
Choosing between medical device market research companies in worldwide requires a focus on respondent quality and therapeutic expertise. For large-scale evidence and clinical-grade data, a firm like IQVIA provides the necessary infrastructure. If your priority is agile testing or specialized qualitative work, providers such as Sago or Ipsos offer deep industry engagement and flexible methodologies.
For projects requiring high-precision access to verified healthcare professionals across a wide range of international markets, Global Vox Populi stands out for its proprietary panel assets and rigorous data quality controls. When selecting your partner, prioritize firms that demonstrate transparency in their recruitment, verification, and compliance processes. Use the scorecard provided to weigh each company against your specific needs, making sure that your chosen provider can deliver the high-fidelity insights required for your medical device strategy.
Planning research worldwide? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
What are the top medical device market research companies?
The leading firms in this space are typically those with dedicated healthcare practices, such as IQVIA, Ipsos, and Escalent. These companies combine deep therapeutic knowledge with solid research methodologies. For firms needing global reach through proprietary panels, Global Vox Populi is also a significant partner, offering verified access to specialized medical audiences in 190+ markets.
How do I choose a market research firm for medical devices?
Start by evaluating their expertise in your specific therapeutic area and their access to the target respondent groups. Prioritize firms that own their panels, as this protects superior control over data quality and verification. Always request evidence of their compliance with international data protection laws and their protocols for reporting adverse events during research.
Do medical device market research companies provide regulatory consulting?
While many research firms provide insights that inform regulatory strategy, not all are full-service regulatory consultancies. Some, like IQVIA, have deep involvement in clinical trials and regulatory support, whereas others focus primarily on market intelligence. Always clarify the scope of their consulting services during the initial project scoping phase to make sure they meet your needs.
What is the difference between syndicated and custom medical device research?
Syndicated research involves purchasing reports or data sets that have already been produced for a wider industry audience; it is generally more cost-effective but less specific to your unique questions. Custom research is designed specifically to address your firm’s unique business questions, providing tailored insights that are proprietary to your brand.
Which market research firms have access to healthcare professional panels?
Several firms, including Global Vox Populi, Ipsos, and Dynata, maintain large, verified panels of healthcare professionals. These firms invest in regular re-profiling and credential verification to make sure their panels remain current and accurate, which is essential for conducting high-quality medical device research.
Are there specialized market research firms for surgical products?
Yes, many of the firms listed, particularly those with dedicated medical device centres of expertise like Ipsos and IQVIA, have deep experience in surgical product research. They often employ researchers with clinical backgrounds who understand the nuances of surgical procedures and the specific needs of surgeons and operating room staff.
How do global market research firms support medical device product launches?
They provide a range of services including market opportunity assessments, concept testing, brand tracking, and post-market surveillance. By conducting research across multiple countries, they help make sure that product positioning and messaging are tailored to local market needs while maintaining a consistent global strategy.
What should I look for in a healthcare-focused research provider?
Look for a strong track record in the healthcare sector, verified respondent panels, and a commitment to data security and compliance. A good provider will be able to demonstrate their understanding of the medical device regulatory environment and show how their research design mitigates the risks associated with reaching specialized, low-incidence populations.